HEADER TRANSPORT PROTEIN 09-MAY-22 7UZE TITLE ERYTHROCYTE ANKYRIN-1 COMPLEX CLASS 2 LOCAL REFINEMENT OF AQP1 (C4 TITLE 2 SYMMETRY APPLIED) COMPND MOL_ID: 1; COMPND 2 MOLECULE: AQUAPORIN-1; COMPND 3 CHAIN: D, B, C, A; COMPND 4 SYNONYM: AQP-1,AQUAPORIN-CHIP,URINE WATER CHANNEL,WATER CHANNEL COMPND 5 PROTEIN FOR RED BLOOD CELLS AND KIDNEY PROXIMAL TUBULE; COMPND 6 OTHER_DETAILS: PALMITOYLATED AT CYS-87 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: ERYTHROCYTES KEYWDS MEMBRANE PROTEIN, ANION EXCHANGE, ERYTHROCYTE, GLYCOPROTEIN, KEYWDS 2 TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR F.VALLESE,K.KIM,L.Y.YEN,J.D.JOHNSTON,A.J.NOBLE,T.CALI,O.B.CLARKE REVDAT 2 27-JUL-22 7UZE 1 JRNL REVDAT 1 20-JUL-22 7UZE 0 JRNL AUTH F.VALLESE,K.KIM,L.Y.YEN,J.D.JOHNSTON,A.J.NOBLE,T.CALI, JRNL AUTH 2 O.B.CLARKE JRNL TITL ARCHITECTURE OF THE HUMAN ERYTHROCYTE ANKYRIN-1 COMPLEX. JRNL REF NAT.STRUCT.MOL.BIOL. V. 29 706 2022 JRNL REFN ESSN 1545-9985 JRNL PMID 35835865 JRNL DOI 10.1038/S41594-022-00792-W REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : LEGINON, CRYOSPARC, COOT, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : BACK PROJECTION REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 4CSK REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.400 REMARK 3 NUMBER OF PARTICLES : 108425 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7UZE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265239. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : LOCAL REFINEMENT OF AQUAPORIN 1 REMARK 245 IN CLASS 2 OF ANKYRIN COMPLEX; REMARK 245 LOCAL C4 SYMMETRY APPLIED. REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 8.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : 4-6 SECONDS, WAIT TIME 30 REMARK 245 SECONDS. REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 14464 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5800.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, B, C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 VAL D 250 REMARK 465 GLU D 251 REMARK 465 GLU D 252 REMARK 465 TYR D 253 REMARK 465 ASP D 254 REMARK 465 LEU D 255 REMARK 465 ASP D 256 REMARK 465 ALA D 257 REMARK 465 ASP D 258 REMARK 465 ASP D 259 REMARK 465 ILE D 260 REMARK 465 ASN D 261 REMARK 465 SER D 262 REMARK 465 ARG D 263 REMARK 465 VAL D 264 REMARK 465 GLU D 265 REMARK 465 MET D 266 REMARK 465 LYS D 267 REMARK 465 PRO D 268 REMARK 465 LYS D 269 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 VAL B 250 REMARK 465 GLU B 251 REMARK 465 GLU B 252 REMARK 465 TYR B 253 REMARK 465 ASP B 254 REMARK 465 LEU B 255 REMARK 465 ASP B 256 REMARK 465 ALA B 257 REMARK 465 ASP B 258 REMARK 465 ASP B 259 REMARK 465 ILE B 260 REMARK 465 ASN B 261 REMARK 465 SER B 262 REMARK 465 ARG B 263 REMARK 465 VAL B 264 REMARK 465 GLU B 265 REMARK 465 MET B 266 REMARK 465 LYS B 267 REMARK 465 PRO B 268 REMARK 465 LYS B 269 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 VAL C 250 REMARK 465 GLU C 251 REMARK 465 GLU C 252 REMARK 465 TYR C 253 REMARK 465 ASP C 254 REMARK 465 LEU C 255 REMARK 465 ASP C 256 REMARK 465 ALA C 257 REMARK 465 ASP C 258 REMARK 465 ASP C 259 REMARK 465 ILE C 260 REMARK 465 ASN C 261 REMARK 465 SER C 262 REMARK 465 ARG C 263 REMARK 465 VAL C 264 REMARK 465 GLU C 265 REMARK 465 MET C 266 REMARK 465 LYS C 267 REMARK 465 PRO C 268 REMARK 465 LYS C 269 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 VAL A 250 REMARK 465 GLU A 251 REMARK 465 GLU A 252 REMARK 465 TYR A 253 REMARK 465 ASP A 254 REMARK 465 LEU A 255 REMARK 465 ASP A 256 REMARK 465 ALA A 257 REMARK 465 ASP A 258 REMARK 465 ASP A 259 REMARK 465 ILE A 260 REMARK 465 ASN A 261 REMARK 465 SER A 262 REMARK 465 ARG A 263 REMARK 465 VAL A 264 REMARK 465 GLU A 265 REMARK 465 MET A 266 REMARK 465 LYS A 267 REMARK 465 PRO A 268 REMARK 465 LYS A 269 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER D 3 OG REMARK 470 LYS D 6 CG CD CE NZ REMARK 470 SER D 236 OG REMARK 470 ASP D 237 CG OD1 OD2 REMARK 470 THR D 239 OG1 CG2 REMARK 470 ASP D 240 CG OD1 OD2 REMARK 470 LYS D 243 CG CD CE NZ REMARK 470 SER D 247 OG REMARK 470 GLN D 249 CG CD OE1 NE2 REMARK 470 SER B 3 OG REMARK 470 LYS B 6 CG CD CE NZ REMARK 470 SER B 236 OG REMARK 470 ASP B 237 CG OD1 OD2 REMARK 470 THR B 239 OG1 CG2 REMARK 470 ASP B 240 CG OD1 OD2 REMARK 470 LYS B 243 CG CD CE NZ REMARK 470 SER B 247 OG REMARK 470 GLN B 249 CG CD OE1 NE2 REMARK 470 SER C 3 OG REMARK 470 LYS C 6 CG CD CE NZ REMARK 470 SER C 236 OG REMARK 470 ASP C 237 CG OD1 OD2 REMARK 470 THR C 239 OG1 CG2 REMARK 470 ASP C 240 CG OD1 OD2 REMARK 470 LYS C 243 CG CD CE NZ REMARK 470 SER C 247 OG REMARK 470 GLN C 249 CG CD OE1 NE2 REMARK 470 SER A 3 OG REMARK 470 LYS A 6 CG CD CE NZ REMARK 470 SER A 236 OG REMARK 470 ASP A 237 CG OD1 OD2 REMARK 470 THR A 239 OG1 CG2 REMARK 470 ASP A 240 CG OD1 OD2 REMARK 470 LYS A 243 CG CD CE NZ REMARK 470 SER A 247 OG REMARK 470 GLN A 249 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH D 415 O HOH D 428 2.04 REMARK 500 O HOH A 414 O HOH A 428 2.04 REMARK 500 O HOH B 416 O HOH B 429 2.04 REMARK 500 O HOH C 416 O HOH C 427 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU D 75 19.76 54.42 REMARK 500 ARG D 159 -8.33 72.16 REMARK 500 CYS D 189 82.75 60.28 REMARK 500 ILE D 191 -1.95 73.00 REMARK 500 ARG B 159 -8.27 72.70 REMARK 500 CYS B 189 70.36 58.77 REMARK 500 ILE B 191 4.55 55.21 REMARK 500 LEU C 75 19.94 54.42 REMARK 500 ARG C 159 -6.79 69.04 REMARK 500 CYS C 189 70.47 58.69 REMARK 500 ILE C 191 -0.46 58.98 REMARK 500 SER C 235 52.93 -94.06 REMARK 500 SER C 235 52.93 -91.38 REMARK 500 ARG A 159 -8.26 71.89 REMARK 500 CYS A 189 70.40 58.92 REMARK 500 ILE A 191 6.65 54.93 REMARK 500 ASN A 192 90.34 -160.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-26886 RELATED DB: EMDB REMARK 900 BAND 3-GLYCOPHORIN A COMPLEX, OUTWARD FACING REMARK 900 RELATED ID: EMD-26874 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26886 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26916 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26917 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26918 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26919 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26940 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26943 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26944 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26948 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26949 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26950 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26951 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26952 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26953 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26954 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26955 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26956 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26958 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26960 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26965 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26974 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26972 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26973 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26975 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26979 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26978 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26988 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26982 RELATED DB: EMDB DBREF 7UZE D 1 269 UNP P29972 AQP1_HUMAN 1 269 DBREF 7UZE B 1 269 UNP P29972 AQP1_HUMAN 1 269 DBREF 7UZE C 1 269 UNP P29972 AQP1_HUMAN 1 269 DBREF 7UZE A 1 269 UNP P29972 AQP1_HUMAN 1 269 SEQRES 1 D 269 MET ALA SER GLU PHE LYS LYS LYS LEU PHE TRP ARG ALA SEQRES 2 D 269 VAL VAL ALA GLU PHE LEU ALA THR THR LEU PHE VAL PHE SEQRES 3 D 269 ILE SER ILE GLY SER ALA LEU GLY PHE LYS TYR PRO VAL SEQRES 4 D 269 GLY ASN ASN GLN THR ALA VAL GLN ASP ASN VAL LYS VAL SEQRES 5 D 269 SER LEU ALA PHE GLY LEU SER ILE ALA THR LEU ALA GLN SEQRES 6 D 269 SER VAL GLY HIS ILE SER GLY ALA HIS LEU ASN PRO ALA SEQRES 7 D 269 VAL THR LEU GLY LEU LEU LEU SER P1L GLN ILE SER ILE SEQRES 8 D 269 PHE ARG ALA LEU MET TYR ILE ILE ALA GLN CYS VAL GLY SEQRES 9 D 269 ALA ILE VAL ALA THR ALA ILE LEU SER GLY ILE THR SER SEQRES 10 D 269 SER LEU THR GLY ASN SER LEU GLY ARG ASN ASP LEU ALA SEQRES 11 D 269 ASP GLY VAL ASN SER GLY GLN GLY LEU GLY ILE GLU ILE SEQRES 12 D 269 ILE GLY THR LEU GLN LEU VAL LEU CYS VAL LEU ALA THR SEQRES 13 D 269 THR ASP ARG ARG ARG ARG ASP LEU GLY GLY SER ALA PRO SEQRES 14 D 269 LEU ALA ILE GLY LEU SER VAL ALA LEU GLY HIS LEU LEU SEQRES 15 D 269 ALA ILE ASP TYR THR GLY CYS GLY ILE ASN PRO ALA ARG SEQRES 16 D 269 SER PHE GLY SER ALA VAL ILE THR HIS ASN PHE SER ASN SEQRES 17 D 269 HIS TRP ILE PHE TRP VAL GLY PRO PHE ILE GLY GLY ALA SEQRES 18 D 269 LEU ALA VAL LEU ILE TYR ASP PHE ILE LEU ALA PRO ARG SEQRES 19 D 269 SER SER ASP LEU THR ASP ARG VAL LYS VAL TRP THR SER SEQRES 20 D 269 GLY GLN VAL GLU GLU TYR ASP LEU ASP ALA ASP ASP ILE SEQRES 21 D 269 ASN SER ARG VAL GLU MET LYS PRO LYS SEQRES 1 B 269 MET ALA SER GLU PHE LYS LYS LYS LEU PHE TRP ARG ALA SEQRES 2 B 269 VAL VAL ALA GLU PHE LEU ALA THR THR LEU PHE VAL PHE SEQRES 3 B 269 ILE SER ILE GLY SER ALA LEU GLY PHE LYS TYR PRO VAL SEQRES 4 B 269 GLY ASN ASN GLN THR ALA VAL GLN ASP ASN VAL LYS VAL SEQRES 5 B 269 SER LEU ALA PHE GLY LEU SER ILE ALA THR LEU ALA GLN SEQRES 6 B 269 SER VAL GLY HIS ILE SER GLY ALA HIS LEU ASN PRO ALA SEQRES 7 B 269 VAL THR LEU GLY LEU LEU LEU SER P1L GLN ILE SER ILE SEQRES 8 B 269 PHE ARG ALA LEU MET TYR ILE ILE ALA GLN CYS VAL GLY SEQRES 9 B 269 ALA ILE VAL ALA THR ALA ILE LEU SER GLY ILE THR SER SEQRES 10 B 269 SER LEU THR GLY ASN SER LEU GLY ARG ASN ASP LEU ALA SEQRES 11 B 269 ASP GLY VAL ASN SER GLY GLN GLY LEU GLY ILE GLU ILE SEQRES 12 B 269 ILE GLY THR LEU GLN LEU VAL LEU CYS VAL LEU ALA THR SEQRES 13 B 269 THR ASP ARG ARG ARG ARG ASP LEU GLY GLY SER ALA PRO SEQRES 14 B 269 LEU ALA ILE GLY LEU SER VAL ALA LEU GLY HIS LEU LEU SEQRES 15 B 269 ALA ILE ASP TYR THR GLY CYS GLY ILE ASN PRO ALA ARG SEQRES 16 B 269 SER PHE GLY SER ALA VAL ILE THR HIS ASN PHE SER ASN SEQRES 17 B 269 HIS TRP ILE PHE TRP VAL GLY PRO PHE ILE GLY GLY ALA SEQRES 18 B 269 LEU ALA VAL LEU ILE TYR ASP PHE ILE LEU ALA PRO ARG SEQRES 19 B 269 SER SER ASP LEU THR ASP ARG VAL LYS VAL TRP THR SER SEQRES 20 B 269 GLY GLN VAL GLU GLU TYR ASP LEU ASP ALA ASP ASP ILE SEQRES 21 B 269 ASN SER ARG VAL GLU MET LYS PRO LYS SEQRES 1 C 269 MET ALA SER GLU PHE LYS LYS LYS LEU PHE TRP ARG ALA SEQRES 2 C 269 VAL VAL ALA GLU PHE LEU ALA THR THR LEU PHE VAL PHE SEQRES 3 C 269 ILE SER ILE GLY SER ALA LEU GLY PHE LYS TYR PRO VAL SEQRES 4 C 269 GLY ASN ASN GLN THR ALA VAL GLN ASP ASN VAL LYS VAL SEQRES 5 C 269 SER LEU ALA PHE GLY LEU SER ILE ALA THR LEU ALA GLN SEQRES 6 C 269 SER VAL GLY HIS ILE SER GLY ALA HIS LEU ASN PRO ALA SEQRES 7 C 269 VAL THR LEU GLY LEU LEU LEU SER P1L GLN ILE SER ILE SEQRES 8 C 269 PHE ARG ALA LEU MET TYR ILE ILE ALA GLN CYS VAL GLY SEQRES 9 C 269 ALA ILE VAL ALA THR ALA ILE LEU SER GLY ILE THR SER SEQRES 10 C 269 SER LEU THR GLY ASN SER LEU GLY ARG ASN ASP LEU ALA SEQRES 11 C 269 ASP GLY VAL ASN SER GLY GLN GLY LEU GLY ILE GLU ILE SEQRES 12 C 269 ILE GLY THR LEU GLN LEU VAL LEU CYS VAL LEU ALA THR SEQRES 13 C 269 THR ASP ARG ARG ARG ARG ASP LEU GLY GLY SER ALA PRO SEQRES 14 C 269 LEU ALA ILE GLY LEU SER VAL ALA LEU GLY HIS LEU LEU SEQRES 15 C 269 ALA ILE ASP TYR THR GLY CYS GLY ILE ASN PRO ALA ARG SEQRES 16 C 269 SER PHE GLY SER ALA VAL ILE THR HIS ASN PHE SER ASN SEQRES 17 C 269 HIS TRP ILE PHE TRP VAL GLY PRO PHE ILE GLY GLY ALA SEQRES 18 C 269 LEU ALA VAL LEU ILE TYR ASP PHE ILE LEU ALA PRO ARG SEQRES 19 C 269 SER SER ASP LEU THR ASP ARG VAL LYS VAL TRP THR SER SEQRES 20 C 269 GLY GLN VAL GLU GLU TYR ASP LEU ASP ALA ASP ASP ILE SEQRES 21 C 269 ASN SER ARG VAL GLU MET LYS PRO LYS SEQRES 1 A 269 MET ALA SER GLU PHE LYS LYS LYS LEU PHE TRP ARG ALA SEQRES 2 A 269 VAL VAL ALA GLU PHE LEU ALA THR THR LEU PHE VAL PHE SEQRES 3 A 269 ILE SER ILE GLY SER ALA LEU GLY PHE LYS TYR PRO VAL SEQRES 4 A 269 GLY ASN ASN GLN THR ALA VAL GLN ASP ASN VAL LYS VAL SEQRES 5 A 269 SER LEU ALA PHE GLY LEU SER ILE ALA THR LEU ALA GLN SEQRES 6 A 269 SER VAL GLY HIS ILE SER GLY ALA HIS LEU ASN PRO ALA SEQRES 7 A 269 VAL THR LEU GLY LEU LEU LEU SER P1L GLN ILE SER ILE SEQRES 8 A 269 PHE ARG ALA LEU MET TYR ILE ILE ALA GLN CYS VAL GLY SEQRES 9 A 269 ALA ILE VAL ALA THR ALA ILE LEU SER GLY ILE THR SER SEQRES 10 A 269 SER LEU THR GLY ASN SER LEU GLY ARG ASN ASP LEU ALA SEQRES 11 A 269 ASP GLY VAL ASN SER GLY GLN GLY LEU GLY ILE GLU ILE SEQRES 12 A 269 ILE GLY THR LEU GLN LEU VAL LEU CYS VAL LEU ALA THR SEQRES 13 A 269 THR ASP ARG ARG ARG ARG ASP LEU GLY GLY SER ALA PRO SEQRES 14 A 269 LEU ALA ILE GLY LEU SER VAL ALA LEU GLY HIS LEU LEU SEQRES 15 A 269 ALA ILE ASP TYR THR GLY CYS GLY ILE ASN PRO ALA ARG SEQRES 16 A 269 SER PHE GLY SER ALA VAL ILE THR HIS ASN PHE SER ASN SEQRES 17 A 269 HIS TRP ILE PHE TRP VAL GLY PRO PHE ILE GLY GLY ALA SEQRES 18 A 269 LEU ALA VAL LEU ILE TYR ASP PHE ILE LEU ALA PRO ARG SEQRES 19 A 269 SER SER ASP LEU THR ASP ARG VAL LYS VAL TRP THR SER SEQRES 20 A 269 GLY GLN VAL GLU GLU TYR ASP LEU ASP ALA ASP ASP ILE SEQRES 21 A 269 ASN SER ARG VAL GLU MET LYS PRO LYS MODRES 7UZE P1L D 87 CYS MODIFIED RESIDUE MODRES 7UZE P1L B 87 CYS MODIFIED RESIDUE MODRES 7UZE P1L C 87 CYS MODIFIED RESIDUE MODRES 7UZE P1L A 87 CYS MODIFIED RESIDUE HET P1L D 87 57 HET P1L B 87 57 HET P1L C 87 57 HET P1L A 87 57 HET CLR D 301 74 HET CLR B 301 74 HET CLR C 301 74 HET CLR A 301 74 HETNAM P1L S-PALMITOYL-L-CYSTEINE HETNAM CLR CHOLESTEROL FORMUL 1 P1L 4(C19 H37 N O3 S) FORMUL 5 CLR 4(C27 H46 O) FORMUL 9 HOH *113(H2 O) HELIX 1 AA1 SER D 3 LYS D 6 5 4 HELIX 2 AA2 LYS D 7 LEU D 33 1 27 HELIX 3 AA3 GLY D 34 TYR D 37 5 4 HELIX 4 AA4 ASP D 48 GLY D 72 1 25 HELIX 5 AA5 ASN D 76 SER D 86 1 11 HELIX 6 AA6 SER D 90 THR D 116 1 27 HELIX 7 AA7 ASN D 134 THR D 157 1 24 HELIX 8 AA8 SER D 167 GLY D 188 1 22 HELIX 9 AA9 ASN D 192 HIS D 204 1 13 HELIX 10 AB1 TRP D 210 ILE D 230 1 21 HELIX 11 AB2 ASP D 237 GLY D 248 1 12 HELIX 12 AB3 SER B 3 LYS B 6 5 4 HELIX 13 AB4 LYS B 7 LEU B 33 1 27 HELIX 14 AB5 GLY B 34 TYR B 37 5 4 HELIX 15 AB6 ASP B 48 GLY B 72 1 25 HELIX 16 AB7 ASN B 76 SER B 86 1 11 HELIX 17 AB8 SER B 90 THR B 116 1 27 HELIX 18 AB9 ASN B 134 THR B 157 1 24 HELIX 19 AC1 SER B 167 GLY B 188 1 22 HELIX 20 AC2 ASN B 192 HIS B 204 1 13 HELIX 21 AC3 TRP B 210 ILE B 230 1 21 HELIX 22 AC4 ASP B 237 GLY B 248 1 12 HELIX 23 AC5 SER C 3 LYS C 6 5 4 HELIX 24 AC6 LYS C 7 LEU C 33 1 27 HELIX 25 AC7 GLY C 34 TYR C 37 5 4 HELIX 26 AC8 ASP C 48 GLY C 72 1 25 HELIX 27 AC9 ASN C 76 SER C 86 1 11 HELIX 28 AD1 SER C 90 THR C 116 1 27 HELIX 29 AD2 ASN C 134 THR C 157 1 24 HELIX 30 AD3 SER C 167 GLY C 188 1 22 HELIX 31 AD4 ASN C 192 HIS C 204 1 13 HELIX 32 AD5 TRP C 210 ILE C 230 1 21 HELIX 33 AD6 ASP C 237 GLY C 248 1 12 HELIX 34 AD7 SER A 3 LYS A 6 5 4 HELIX 35 AD8 LYS A 7 LEU A 33 1 27 HELIX 36 AD9 GLY A 34 TYR A 37 5 4 HELIX 37 AE1 ASP A 48 GLY A 72 1 25 HELIX 38 AE2 ASN A 76 SER A 86 1 11 HELIX 39 AE3 SER A 90 THR A 116 1 27 HELIX 40 AE4 ASN A 134 THR A 157 1 24 HELIX 41 AE5 SER A 167 GLY A 188 1 22 HELIX 42 AE6 ASN A 192 HIS A 204 1 13 HELIX 43 AE7 TRP A 210 ILE A 230 1 21 HELIX 44 AE8 ASP A 237 GLY A 248 1 12 LINK C SER D 86 N P1L D 87 1555 1555 1.33 LINK C P1L D 87 N GLN D 88 1555 1555 1.33 LINK C SER B 86 N P1L B 87 1555 1555 1.33 LINK C P1L B 87 N GLN B 88 1555 1555 1.33 LINK C SER C 86 N P1L C 87 1555 1555 1.33 LINK C P1L C 87 N GLN C 88 1555 1555 1.33 LINK C SER A 86 N P1L A 87 1555 1555 1.33 LINK C P1L A 87 N GLN A 88 1555 1555 1.33 CISPEP 1 TYR D 37 PRO D 38 0 4.85 CISPEP 2 TYR B 37 PRO B 38 0 4.81 CISPEP 3 TYR C 37 PRO C 38 0 4.80 CISPEP 4 TYR A 37 PRO A 38 0 5.14 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000